Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 8701-8750 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05392114
A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
PHASE3
Active, not recruiting
154 participants
Started: Jul 13, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
50 locations
NCT06390904
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients
PHASE2/PHASE3
Active, not recruiting
29 participants
Started: Jul 13, 2022 · Completed: Jul 30, 2027
3 conditions
1 sponsor
2 locations
NCT05406713
Pembrolizumab in Muscle-invasive Bladder Cancer
PHASE2
Active, not recruiting
46 participants
Started: Jul 13, 2022 · Completed: Jan 31, 2028
3 conditions
2 sponsors
4 locations
NCT05246514
A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
PHASE2
Active, not recruiting
72 participants
Started: Jul 13, 2022 · Completed: Mar 16, 2026
1 condition
2 sponsors
28 locations
NCT05302752
Quantification and Repeatability of Magnetic Stimulation
NA
Active, not recruiting
16 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05226780
Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE
PHASE2
Active, not recruiting
8 participants
Started: Jul 12, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
4 locations
NCT05353647
A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)
PHASE2
Active, not recruiting
25 participants
Started: Jul 12, 2022 · Completed: Jul 31, 2027
1 condition
5 sponsors
9 locations
NCT05679570
Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)
PHASE2
Active, not recruiting
20 participants
Started: Jul 12, 2022 · Completed: Jun 30, 2026
1 condition
4 sponsors
9 locations
NCT05470218
Leucine, MTOR and Athero
NA
Active, not recruiting
10 participants
Started: Jul 12, 2022 · Completed: Aug 14, 2026
1 condition
2 sponsors
1 location
NCT06310343
ADAs to Alemtuzumab
N/A
Active, not recruiting
15 participants
Started: Jul 12, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05438953
Follow-up of People at Risk of Monkeypox Infection: a Prospective Cohort Study
NA
Active, not recruiting
164 participants
Started: Jul 12, 2022 · Completed: Oct 31, 2024
2 conditions
1 sponsor
1 location
NCT05301673
ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence
N/A
Active, not recruiting
600 participants
Started: Jul 12, 2022 · Completed: Mar 31, 2025
3 conditions
14 sponsors
2 locations
NCT05435313
Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy
PHASE2
Active, not recruiting
39 participants
Started: Jul 12, 2022 · Completed: Feb 29, 2024
1 condition
1 sponsor
1 location
NCT05460533
A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)
PHASE2
Active, not recruiting
30 participants
Started: Jul 12, 2022 · Completed: Jul 31, 2026
1 condition
2 sponsors
6 locations
NCT05458284
The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment
PHASE2
Active, not recruiting
80 participants
Started: Jul 11, 2022 · Completed: Jul 31, 2026
2 conditions
2 sponsors
7 locations
NCT05467540
SPINERY™ A Novel Radio-Frequency Tumor Ablation Device Study
NA
Active, not recruiting
52 participants
Started: Jul 11, 2022 · Completed: Nov 30, 2024
1 condition
1 sponsor
5 locations
NCT05245201
Clinical Decision Support for PrEP
NA
Active, not recruiting
4 participants
Started: Jul 11, 2022 · Completed: Aug 31, 2027
2 conditions
5 sponsors
3 locations
NCT05148715
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)
PHASE2
Active, not recruiting
414 participants
Started: Jul 11, 2022 · Completed: Jan 31, 2026
3 conditions
2 sponsors
9 locations
NCT05111899
Leading Advancements in the Uptake of Newborn Community Health
NA
Active, not recruiting
316 participants
Started: Jul 11, 2022 · Completed: Apr 1, 2024
3 conditions
3 sponsors
1 location
NCT06582511
Evaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry Age-Related Macular Degeneration Patients
N/A
Active, not recruiting
30 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05164055
Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)
PHASE4
Active, not recruiting
17 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
11 locations
NCT05217446
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
PHASE2
Active, not recruiting
107 participants
Started: Jul 11, 2022 · Completed: Jan 26, 2027
1 condition
4 sponsors
64 locations
NCT04965636
Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
PHASE3
Active, not recruiting
16 participants
Started: Jul 11, 2022 · Completed: Oct 9, 2025
1 condition
1 sponsor
14 locations
NCT05460273
A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)
PHASE1/PHASE2
Active, not recruiting
119 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
21 locations
NCT05142241
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
PHASE2
Active, not recruiting
14 participants
Started: Jul 11, 2022 · Completed: Sep 29, 2026
4 conditions
1 sponsor
2 locations
NCT05433350
Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients
PHASE2/PHASE3
Active, not recruiting
35 participants
Started: Jul 9, 2022 · Completed: Mar 31, 2026
3 conditions
1 sponsor
6 locations
NCT05614765
Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment
N/A
Active, not recruiting
18,000 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05360446
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
PHASE3
Active, not recruiting
610 participants
Started: Jul 8, 2022 · Completed: Oct 26, 2026
1 condition
1 sponsor
89 locations
NCT06087679
The SongDanceT1 Study: Stress, Ongoing Self- Monitoring and Diabetes, Nerve Stimulation and Cognitive Empowerment.
NA
Active, not recruiting
120 participants
Started: Jul 8, 2022 · Completed: Feb 1, 2024
2 conditions
2 sponsors
1 location
NCT05338970
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
PHASE3
Active, not recruiting
586 participants
Started: Jul 8, 2022 · Completed: Jun 30, 2026
3 conditions
2 sponsors
182 locations
NCT06223932
Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.
N/A
Active, not recruiting
2,600 participants
Started: Jul 7, 2022 · Completed: Feb 29, 2024
2 conditions
2 sponsors
8 locations
NCT05464823
Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma
NA
Active, not recruiting
111 participants
Started: Jul 7, 2022 · Completed: May 12, 2027
1 condition
1 sponsor
1 location
NCT05116527
THC Memory & Reward Learning Pilot
PHASE1/PHASE2
Active, not recruiting
20 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT05377281
Feasibility and Safety of AutoloGous UncondItioneD PEripheral Nerve Tissue Delivery to the Substantia Nigra (GUIDE)
PHASE1
Active, not recruiting
10 participants
Started: Jul 7, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05573984
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
N/A
Active, not recruiting
50 participants
Started: Jul 7, 2022 · Completed: Feb 28, 2026
5 conditions
1 sponsor
7 locations
NCT05161195
Roll-over Study to Allow Continued Access to Ribociclib
PHASE4
Active, not recruiting
134 participants
Started: Jul 7, 2022 · Completed: Aug 14, 2030
1 condition
1 sponsor
74 locations
NCT04963153
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy
PHASE1
Active, not recruiting
30 participants
Started: Jul 7, 2022 · Completed: Dec 1, 2026
20 conditions
1 sponsor
10 locations
NCT05505799
Community Medical Center, Continuous Quality Improvement Project, Rapid Sequence Intubation
NA
Active, not recruiting
700 participants
Started: Jul 7, 2022 · Completed: Jun 30, 2025
3 conditions
1 sponsor
1 location
NCT05413135
Study of ARO-APOC3 in Adults With Dyslipidemia
PHASE2
Active, not recruiting
418 participants
Started: Jul 7, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
60 locations
NCT05282901
Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)
PHASE2
Active, not recruiting
51 participants
Started: Jul 7, 2022 · Completed: Nov 15, 2026
1 condition
2 sponsors
1 location
NCT05361902
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer
NA
Active, not recruiting
35 participants
Started: Jul 7, 2022 · Completed: Feb 28, 2027
1 condition
1 sponsor
1 location
NCT04919512
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder
PHASE2
Active, not recruiting
163 participants
Started: Jul 7, 2022 · Completed: Mar 7, 2027
1 condition
1 sponsor
109 locations
NCT04881799
Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity
EARLY_PHASE1
Active, not recruiting
13 participants
Started: Jul 7, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05356884
Adolescent-mediated Family Diabetes Intervention: American Samoa
NA
Active, not recruiting
360 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05381909
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
PHASE1
Active, not recruiting
157 participants
Started: Jul 6, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
34 locations
NCT05291091
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
PHASE2
Active, not recruiting
175 participants
Started: Jul 6, 2022 · Completed: Aug 31, 2026
1 condition
4 sponsors
51 locations
NCT05371834
Microwave Treatment of Common and Plantar Warts
NA
Active, not recruiting
119 participants
Started: Jul 6, 2022 · Completed: Mar 31, 2025
1 condition
2 sponsors
6 locations
NCT05434663
Safety Study of Repeat Doses of SUSTOL in Adults
PHASE4
Active, not recruiting
300 participants
Started: Jul 6, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
2 locations
NCT05219435
Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer
PHASE2
Active, not recruiting
66 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
12 locations
NCT05337553
A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy
PHASE3
Active, not recruiting
269 participants
Started: Jul 6, 2022 · Completed: Jan 31, 2026
3 conditions
1 sponsor
53 locations
Previous
1
More pages
172
173
174
175
176
177
178
More pages
431
Next